Salivary α-amylase as a marker of sleep disorders: A theoretical review

Sleep Med Rev. 2024 Apr:74:101894. doi: 10.1016/j.smrv.2023.101894. Epub 2023 Dec 22.

Abstract

Sleep disorders are commonplace in our modern societies. Specialized hospital departments are generally overloaded, and sleep assessment is an expensive process in terms of equipment, human resources, and time. Biomarkers would usefully complement current measures in the screening and follow-up of sleep disorders and their daytime repercussions. Among salivary markers, a growing body of literature suggests that salivary α-amylase (sAA) may be a cross-species marker of sleep debt. However, there is no consensus as to the direction of variation in sAA with sleep disorders. Herein, after describing the mechanisms of sAA secretion and its relationship with stress, studies assessing the relationship between sAA and sleep parameters are reviewed. Finally, the influence of confounding factors is discussed, along with methodological considerations, to better understand the fluctuations in sAA and facilitate future studies in the field.

Keywords: Biomarkers; Saliva; Sleep disorders; Sleepiness.

Publication types

  • Review

MeSH terms

  • Humans
  • Hydrocortisone
  • Saliva
  • Salivary alpha-Amylases*
  • Sleep
  • Sleep Deprivation

Substances

  • Salivary alpha-Amylases
  • Hydrocortisone